Serotonin noradrenaline reuptake inhibitor (SNRI); major active metabolite of venlafaxine, q.v. Prepn: G. E. M. Husbands et al., EP 112669; eidem, US 4535186 (1984, 1985 both to Am. Home Prod.); J. P. Yardley et al., J. Med. Chem. 33, 2899 (1990) DOI PubMed. CE determn of enantiomers: S. Rudaz et al., J. Pharm. Biomed. Anal. 23, 107 (2000) DOI PubMed. LC/MS/MS determn in plasma: J. Bhatt et al., J. Chromatogr. B 829, 75 (2005) DOI PubMed. Pharmacological profile in animals: E. A. Muth et al., Drug Dev. Res. 23, 191 (1991) DOI. Mechanism of action study: D. C. Deecher et al., J. Pharmacol. Exp. Ther. 318, 657 (2006) DOI PubMed. Preclinical model in treatment of vasomotor symptoms associated with menopause: idem et al., Endocrinology 148, 1376 (2007) DOI PubMed. Clinical trial in major depressive disorder: N. A. DeMartinis et al., J. Clin. Psychiatry 68, 677 (2007) PubMed.
Antidepressant.
Antidepressant; Serotonin Noradrenaline Reuptake Inhibitor (SNRI)